この情報は教育目的のみに提供されています。必ず医療専門家にご相談ください。 詳しく見る

Xl - 3 Allergy

Over-the-Counter

商品名: XL - 3 Allergy

剤形
Tablet
投与経路
ORAL
製造会社
Selder, S.A. de C.V.

About This Medication

Oral preparation used for symptom management and health support.

有効成分

成分 含有量
Loratadine -

適応症と用法

Use(s) temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose itchy, watery eyes sneezing itching of the nose or throat

用量と投与方法

Directions Adults and children 6 years and over: 1 tablet daily; not more than 1 tablet in 24 hours Children under 6 years of age: ask a doctor Consumers with liver or kidney disease: ask a doctor

警告と注意事項

Frequently Asked Questions

Use(s) temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose itchy, watery eyes sneezing itching of the nose or throat

Directions Adults and children 6 years and over: 1 tablet daily; not more than 1 tablet in 24 hours Children under 6 years of age: ask a doctor Consumers with liver or kidney disease: ask a doctor

Warnings Do not use if you have ever had an allergic reaction to this product or any of its ingredients Ask a doctor before use if you have liver or kidney disease. Your doctor should determine if you need a different dose. When using this product do not take more than directed. Taking more than directed may cause drowsiness. Stop use and ask a doctor if if an allergic reaction to this product occurs. Seek medical help right away. If …

Xl - 3 Allergy is available over the counter (OTC) without a prescription.

Similar Tablet Products

Browse all Tablet products →

References & Data Sources

医療免責事項

このページの情報は教育目的のみを意図しており、専門家による医療アドバイス、診断、または治療の代替として使用すべきではありません。

疾患や医薬品に関するご質問がある場合は、必ず担当医またはその他の資格を持つ医療専門家にご相談ください。

データソース: DailyMed (NLM), openFDA, MFDS

Medical Disclaimer

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.